ID L_RVFVZ Reviewed; 2149 AA. AC P27316; DT 01-AUG-1992, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1992, sequence version 1. DT 24-JAN-2024, entry version 85. DE RecName: Full=RNA-directed RNA polymerase L; DE Short=Protein L; DE EC=2.7.7.48 {ECO:0000269|PubMed:34787453}; DE AltName: Full=Large structural protein; DE AltName: Full=Replicase; DE AltName: Full=Transcriptase; DE Includes: DE RecName: Full=cap-snatching endonuclease; DE EC=3.1.-.- {ECO:0000250|UniProtKB:I0DF35}; GN Name=L; OS Rift valley fever virus (strain ZH-548 M12) (RVFV). OC Viruses; Riboviria; Orthornavirae; Negarnaviricota; Polyploviricotina; OC Ellioviricetes; Bunyavirales; Phenuiviridae; Phlebovirus; OC Phlebovirus riftense. OX NCBI_TaxID=11589; OH NCBI_TaxID=7158; Aedes. OH NCBI_TaxID=9913; Bos taurus (Bovine). OH NCBI_TaxID=297284; Bos taurus x Bison bison (beefalo). OH NCBI_TaxID=9837; Camelus bactrianus (Bactrian camel). OH NCBI_TaxID=9925; Capra hircus (Goat). OH NCBI_TaxID=9606; Homo sapiens (Human). OH NCBI_TaxID=9940; Ovis aries (Sheep). OH NCBI_TaxID=29031; Phlebotomus papatasi (Sandfly). RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC RNA]. RX PubMed=1923828; DOI=10.1093/nar/19.19.5433; RA Mueller R., Argentini C., Bouloy M., Prehaud C., Bishop D.H.L.; RT "Completion of the genome sequence of Rift Valley fever phlebovirus RT indicates that the L RNA is negative sense and codes for a putative RT transcriptase-replicase."; RL Nucleic Acids Res. 19:5433-5433(1991). RN [2] RP SUBUNIT. RC STRAIN=MP12; RX PubMed=19812169; DOI=10.1128/jvi.01310-09; RA Zamoto-Niikura A., Terasaki K., Ikegami T., Peters C.J., Makino S.; RT "Rift valley fever virus L protein forms a biologically active oligomer."; RL J. Virol. 83:12779-12789(2009). RN [3] RP INTERACTION WITH GLYCOPROTEIN N. RX PubMed=21445316; DOI=10.1371/journal.pone.0018070; RA Piper M.E., Sorenson D.R., Gerrard S.R.; RT "Efficient cellular release of Rift Valley fever virus requires genomic RT RNA."; RL PLoS ONE 6:E18070-E18070(2011). RN [4] RP FUNCTION. RX PubMed=23824541; DOI=10.1101/gad.215384.113; RA Hopkins K.C., McLane L.M., Maqbool T., Panda D., Gordesky-Gold B., RA Cherry S.; RT "A genome-wide RNAi screen reveals that mRNA decapping restricts bunyaviral RT replication by limiting the pools of Dcp2-accessible targets for cap- RT snatching."; RL Genes Dev. 27:1511-1525(2013). RN [5] RP FUNCTION, AND MUTAGENESIS OF ASP-111. RX PubMed=23698297; DOI=10.1128/jvi.00371-13; RA Klemm C., Reguera J., Cusack S., Zielecki F., Kochs G., Weber F.; RT "Systems to establish bunyavirus genome replication in the absence of RT transcription."; RL J. Virol. 87:8205-8212(2013). RN [6] RP REVIEW. RX PubMed=28418734; DOI=10.1080/1040841x.2017.1307805; RA Amroun A., Priet S., de Lamballerie X., Querat G.; RT "Bunyaviridae RdRps: structure, motifs, and RNA synthesis machinery."; RL Crit. Rev. Microbiol. 43:753-778(2017). RN [7] RP REVIEW. RX PubMed=31948728; DOI=10.1016/j.tim.2019.12.006; RA Olschewski S., Cusack S., Rosenthal M.; RT "The Cap-Snatching Mechanism of Bunyaviruses."; RL Trends Microbiol. 28:293-303(2020). RN [8] RP INTERACTION WITH NUCLEOPROTEIN N. RX PubMed=33952635; DOI=10.1128/jvi.00429-21; RA Tercero B., Narayanan K., Terasaki K., Makino S.; RT "Characterization of the Molecular Interactions That Govern the Packaging RT of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles."; RL J. Virol. 95:e0042921-e0042921(2021). RN [9] RP STRUCTURE BY ELECTRON MICROSCOPY (3.60 ANGSTROMS) OF 216-, COFACTOR, RP CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-111. RX PubMed=34787453; DOI=10.1128/jvi.01713-21; RA Wang X., Hu C., Ye W., Wang J., Dong X., Xu J., Li X., Zhang M., Lu H., RA Zhang F., Wu W., Dai S., Wang H.W., Chen Z.; RT "Structure of Rift Valley Fever Virus RNA-Dependent RNA Polymerase."; RL J. Virol. 96:e0171321-e0171321(2022). CC -!- FUNCTION: RNA-dependent RNA polymerase, which is responsible for the CC replication and transcription of the viral RNA genome using antigenomic CC RNA as an intermediate (PubMed:23698297). During transcription, CC synthesizes subgenomic RNAs and assures their capping by a cap- CC snatching mechanism, which involves the endonuclease activity cleaving CC the host capped pre-mRNAs (PubMed:23824541). These short capped RNAs CC are then used as primers for viral transcription. The 3'-end of CC subgenomic mRNAs molecules are not polyadenylated. During replication, CC the polymerase binds the 5' and 3' vRNA extremities at distinct sites CC (By similarity). In turn, significant conformational changes occur in CC the polymerase and in vRNA to initiate active RNA synthesis (By CC similarity). As a consequence of the use of the same enzyme for both CC transcription and replication, these mechanisms need to be well CC coordinated (By similarity). {ECO:0000250|UniProtKB:A5HC98, CC ECO:0000250|UniProtKB:I0DF35, ECO:0000269|PubMed:23698297, CC ECO:0000269|PubMed:23824541}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + CC RNA(n+1); Xref=Rhea:RHEA:21248, Rhea:RHEA-COMP:14527, Rhea:RHEA- CC COMP:17342, ChEBI:CHEBI:33019, ChEBI:CHEBI:61557, ChEBI:CHEBI:140395; CC EC=2.7.7.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU00539, CC ECO:0000269|PubMed:34787453}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:34787453}; CC Note=For endonuclease activity. Binds 2 Mn(2+) ions in the active site CC (PubMed:34787453). The divalent metal ions are crucial for catalytic CC activity (PubMed:31948728). {ECO:0000269|PubMed:31948728, CC ECO:0000269|PubMed:34787453}; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:34787453}; CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:34787453}; CC Note=For polymerase activity. Initiation activity is stronger in the CC presence of Mn(2+) than in the presence of Mg(2+). CC {ECO:0000269|PubMed:34787453}; CC -!- SUBUNIT: Homomultimer (PubMed:19812169). Interacts with glycoprotein N; CC this interaction allows efficient polymerase packaging into virus CC particles (PubMed:21445316). Interacts with nucleoprotein N CC (PubMed:33952635). {ECO:0000269|PubMed:19812169, CC ECO:0000269|PubMed:21445316, ECO:0000269|PubMed:33952635}. CC -!- SUBCELLULAR LOCATION: Host Golgi apparatus CC {ECO:0000250|UniProtKB:I0DF35}. Host endoplasmic reticulum CC {ECO:0000250|UniProtKB:I0DF35}. Host endoplasmic reticulum-Golgi CC intermediate compartment {ECO:0000250|UniProtKB:I0DF35}. Virion CC {ECO:0000250|UniProtKB:P20470}. CC -!- DOMAIN: The N-terminus contains the endonuclease activity (endoN) (By CC similarity). The central region contains the RdRp activity (By CC similarity). The C-terminus contains the cap-binding region (By CC similarity). {ECO:0000250|UniProtKB:A2SZS3, CC ECO:0000250|UniProtKB:A5HC98, ECO:0000250|UniProtKB:I0DF35}. CC -!- MISCELLANEOUS: Classified as His(+) endonuclease since it has a CC histidine upstream of the active site that coordinates the first CC cation. {ECO:0000303|PubMed:31948728}. CC -!- SIMILARITY: Belongs to the Bunyavirales RNA polymerase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X56464; CAA39836.1; -; Genomic_RNA. DR PIR; S18676; S18676. DR PDB; 7EEI; X-ray; 3.60 A; A=216-1990. DR PDBsum; 7EEI; -. DR EMDB; EMD-31077; -. DR SMR; P27316; -. DR Proteomes; UP000002477; Genome. DR GO; GO:0044165; C:host cell endoplasmic reticulum; IEA:UniProtKB-SubCell. DR GO; GO:0044172; C:host cell endoplasmic reticulum-Golgi intermediate compartment; IEA:UniProtKB-SubCell. DR GO; GO:0044177; C:host cell Golgi apparatus; IEA:UniProtKB-SubCell. DR GO; GO:0044423; C:virion component; IEA:UniProtKB-KW. DR GO; GO:0016787; F:hydrolase activity; IEA:UniProtKB-KW. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0001882; F:nucleoside binding; IEA:InterPro. DR GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW. DR GO; GO:0003968; F:RNA-dependent RNA polymerase activity; IEA:UniProtKB-KW. DR GO; GO:0006351; P:DNA-templated transcription; IEA:InterPro. DR GO; GO:0039689; P:negative stranded viral RNA replication; ISS:UniProtKB. DR GO; GO:0039696; P:RNA-templated viral transcription; ISS:UniProtKB. DR InterPro; IPR022531; L_PA-C-like. DR InterPro; IPR029124; L_protein_N. DR InterPro; IPR007099; RNA-dir_pol_NSvirus. DR InterPro; IPR014385; RNA-dir_pol_phlebovirus. DR InterPro; IPR007322; RNA_pol_bunyavir. DR Pfam; PF04196; Bunya_RdRp; 1. DR Pfam; PF12603; L_PA-C-like; 1. DR Pfam; PF15518; L_protein_N; 1. DR PIRSF; PIRSF000826; L_PhleboV; 1. DR PROSITE; PS50525; RDRP_SSRNA_NEG_SEG; 1. PE 1: Evidence at protein level; KW 3D-structure; Host endoplasmic reticulum; Host Golgi apparatus; Hydrolase; KW Magnesium; Manganese; Metal-binding; Nucleotide-binding; KW Nucleotidyltransferase; Reference proteome; RNA-directed RNA polymerase; KW Transferase; Viral RNA replication; Virion. FT CHAIN 1..2149 FT /note="RNA-directed RNA polymerase L" FT /id="PRO_0000222023" FT DOMAIN 975..1166 FT /note="RdRp catalytic" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00539" FT REGION 18..216 FT /note="Endonuclease" FT /evidence="ECO:0000250|UniProtKB:A5HC98" FT REGION 1706..1822 FT /note="Cap-binding" FT /evidence="ECO:0000250|UniProtKB:A5HC98" FT ACT_SITE 143 FT /note="For endonuclease activity" FT /evidence="ECO:0000250|UniProtKB:I0DF35" FT BINDING 79 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:A5HC98" FT BINDING 111 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000305|PubMed:23698297" FT BINDING 111 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="2" FT /evidence="ECO:0000305|PubMed:23698297" FT BINDING 125 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /ligand_label="1" FT /evidence="ECO:0000250|UniProtKB:A5HC98" FT BINDING 1134 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /ligand_note="catalytic; for RdRp activity" FT /evidence="ECO:0000250|UniProtKB:I0DF35" FT MUTAGEN 111 FT /note="D->A: Loss of transcriptional activity but fully FT active in replication." FT /evidence="ECO:0000269|PubMed:23698297" FT MUTAGEN 111 FT /note="D->A: RNA synthesis products are still produced." FT /evidence="ECO:0000269|PubMed:34787453" SQ SEQUENCE 2149 AA; 243591 MW; 8D5739C6079A88D7 CRC64; MDSILSKQLV DKTGFVRVPI KHFDCTMLTL ALPTFDVSKM VDRITIDFNL DDIQGASEIG STLLPSMSID VEDMANFVHD FTFGHLADKT DRLLMREFPM MNDGFDHLSP DMIIKTTSGV YNIVEFTNFR GDERGAFQAA MIKLAKYEVP CENRSQGRTV VLYVVSAYRA WCMVYLELER TLKQREMVYR YRLALSVMDE LRTLFPELSS TDEELGKTER ELPAMVSSIQ INWSVTESVF PPFSREMFDR FRSSPPDSEY ITRIVSRCLI NSQEKLINSS FFAEGNDKAL RFSKNAEECS LAVERALNQY RAEDNLRDLN DHKSTIQLPP WLSYHDVDGK DLCPLQGLDV RGDHPMCNLW REVVTSANLE EIERMHDDAA AELEFAFGSK GQARERNRYH RVHLNMGSDV LVYIAALGVN GKKHKADTLV QQMRDRSKQP FSPDHDVITY LNFSLHALVT CGQQMRTCTA LSLVIRDSVG SPEDSSAILV RKGFHEIITE HYKFMGSRIG HGCQMVSLIG AELSASVKQH VKPNYFVIKR LLGSGIFLLI KPTSSKSHIF VSFALSALAG PLISPLPGFS SPTKMLGILL VTDFVSYKLS KLTNLCKCVS LMESSFSFWA EAFGIQAGTL VGDFVPRSSD SAAMDASYMG KLSLLTLLED KAATEELQTI ARYIIMEGFV SPPEIPKPHK MTSKFPKVLR SELQVYLLNC LCRTIQRIAG EPFILKKKDG SISWGGMFNP FSGRPLLDMQ PLISCCYNGY FKNKEEETEP SSLSGMYKKI IELEHLRPQS DAFLGYKDPE LPRMHEFSVS YLKEACNHAK LVLRSLYGQN FMEQIDNQII RELSGLTLER LATLKATSNF NENWYVYKDV ADKNYTRDKL LVKMSKYASE GKSLAIQKFE DCMRQIESQG CMHICLFKKQ QHGGLREIYV MGAEERIVQS VVETIARSIG KFFASDTLCN PPNKVKIPET HGIRARKQCK GPVWTCATSD DARKWNQGHF VTKFALMLCE FTSPKWWPLI IRGCSMFTKK RMMMNLNYLK ILDGHRELDI RDDFVMDLFK AYHGEAEVPW AFKGKTYLET TTGMMQGILH YTSSLLHTIH QEYIRSLSFK IFNLKVAPEM SKSLVCDMMQ GSDDSSMLIS FPADDEKVLT RCKVAAAICF RMKKELGVYL AIYPSEKSTA NTDFVMEYNS EFYFHTQHVR PTIRWIAACC SLPEVETLVA RQEEASNLMT SVTEGGGSFS LAAIIQQAQC TLHYMLMGMG VSELFLEYKK AVLKWNDPGL GFFLLDNPYA CGLGGFRFNL FKAITRTDLQ KLYAFFMKKV KGSAARDWAD EDVTIPETCS VSPGGALILS SSLKWGSRKK FQKLRDRLNI PENWIELINE NPEVLYRAPR TGPEILLRIA EKVHSPGVVS SLSSGNAVCK VMASAVYFLS ATIFEDTGRP EFNFLEDSKY SLLQKMAAYS GFHGFNDMEP EDILFLFPNI EELESLDSIV YNKGEIDIIP RVNIRDATQT RVTIFNEQKN LRTSPEKLVS DKWFGTQKSR IGKTTFLAEW EKLKKIVKWL EDAPEATLAH TPLNNHIQVR NFFARMESKP RTVRITGAPV KKRSGVSKIA MVIRDHFSRM GHLRGVEDLA GFTRSVSAEI LKHFLFCILQ GPYSESYKLQ LIYRVLSSVS NVEIKESDGK TKTNLIGILQ RFLDGDHVVP IIEEMGAGTV GGFIKRQQSK VVQNKVVYYG VGIWRGFMDG YQVHLEIEND IGQPPRLRNV TTNCQSSPWD LSIPIRQWAE DMGVTNNQDY SSKSSRGARY WMHSFRMQGP SKPFGCPVYI IKGDMSDVIR LRKEEVEMKV RGSTLNLYTK HHSHQDLHIL SYTASDNDLS PGIFKSISDE GVAQALQLFE REPSNCWVRC ESVAPKFISA ILEICEGKRQ IKGINRTRLS EIVRICSESS LRSKVGSMFS FVANVEEAHD VDYDALMDLM IEDAKNNAFS HVVDCIELDV SGPYEMESFH GRSTLTCTPS TILIRTYTFY LTLHQTMISV QAFQVILDEG VLLIALVNNY LRGSKANCWV RCESVAPKFI SAILEICEGK RQIKGINRTR LSEIVEFVLN LPKIKSRIYV LICRQCHGAN FPPISVRRLM LEDIASVARR LIIVASFGS //